Osprey Private Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.52M Buy
35,180
+1,360
+4% +$159K 1.17% 31
2026
Q1
$4.07M Buy
33,820
+4,580
+16% +$529K 1.18% 30
2025
Q4
$3.08M Buy
29,240
+14,015
+92% +$1.32M 0.89% 32
2025
Q3
$1.28M Buy
15,225
+8,900
+141% +$733K 0.46% 39
2025
Q2
$512K Buy
6,325
+700
+12% +$55.6K 0.28% 39
2025
Q1
$505K Buy
5,625
+2,500
+80% +$233K 0.3% 40
2024
Q4
$311K Buy
3,125
+75
+2% +$7.73K 0.22% 41
2024
Q3
$346K Buy
+3,050
New +$362K 0.24% 41

Other funds holding MRK

Osprey Private Wealth's MRK Position: Q2 2026 in Review

Osprey Private Wealth increased its Merck (MRK) stake by 4% in Q2 2026, buying an estimated $159K and bringing the position to 35,180 shares worth $4.52M. The position accounts for 1.17% of the portfolio, ranked #31.

Osprey Private Wealth first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Osprey Private Wealth held 35,180 shares of Merck worth $4.52M as of Q2 2026.
  • Osprey Private Wealth bought 1,360 Merck shares in Q2 2026, an estimated $159K.
  • Merck made up 1.17% of Osprey Private Wealth's portfolio in Q2 2026, its #31 holding.
  • Osprey Private Wealth first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Osprey Private Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.